Cyclin D1 is probably the most extensively studied cyclin in breast tumors, and its overexpression has been reported in more than 50% of breast cancer cases, as detected in TNBC and hormone-independent HER2+ [224,225]. The gene discussed is ERBB2; the disease is breast cancer.